Has Abbott Molecular, Inc. had other FDA enforcement actions?

Yes. Argus HQ has recorded 12 total FDA actions tied to Abbott Molecular, Inc.: 0 warning letters, 12 recalls, 0 approval records, and 0 Form 483 inspection citations.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2025-05-21; Argus observed and indexed it on 2026-07-16.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_recall · device_recall · high

Abbott Molecular, Inc. — Class II recall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a mul…

Name: FDA Recall Record — Abbott Molecular, Inc.
Creator: Argus HQ
Published: 2025-05-21
License: https://argushq.ai/methodology

Event date: 2025-05-21 00:00:00Z
Observed: 2026-07-16 23:20:09Z
Source ID: Z-1748-2025
Payload hash: f02ebacf1725b5494000fd7f…

Summary

There were reports of an increase in reactive negative controls and false positive results. Status: Ongoing.

Entities

Abbott Molecular, Inc.

View source record ↗

Frequently asked questions

Has Abbott Molecular, Inc. had other FDA enforcement actions?: Yes. Argus HQ has recorded 12 total FDA actions tied to Abbott Molecular, Inc.: 0 warning letters, 12 recalls, 0 approval records, and 0 Form 483 inspection citations.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Recall, tagged high severity by Argus HQ. FDA published the underlying record on 2025-05-21; Argus observed and indexed it on 2026-07-16.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2025). Abbott Molecular, Inc. — Class II recall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a mul…. Digital Empire Holdings LLC. Retrieved from https://argushq.ai/events/fda-recall-abbott-molecular-inc-z-1748-2025

MLA

"Abbott Molecular, Inc. — Class II recall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a mul…." Argus HQ Research, Digital Empire Holdings LLC, 2025, argushq.ai/events/fda-recall-abbott-molecular-inc-z-1748-2025.

Chicago

Argus HQ Research. "Abbott Molecular, Inc. — Class II recall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a mul…." Digital Empire Holdings LLC. Accessed July 23, 2026. https://argushq.ai/events/fda-recall-abbott-molecular-inc-z-1748-2025.

BibTeX

@misc{argushq_argushq_ai_events_fda_recall_abbott_molecular_inc_z_1748_2025_2025,
  title = {Abbott Molecular, Inc. — Class II recall: Alinity m Resp-4-Plex Amplification (AMP) Kit (CE), List Number 09N79-090, a mul…},
  author = {{Argus HQ Research}},
  year = {2025},
  publisher = {Digital Empire Holdings LLC},
  url = {https://argushq.ai/events/fda-recall-abbott-molecular-inc-z-1748-2025},
  note = {Accessed: July 23, 2026}
}

Informational only. Not legal, financial, or medical advice.